A pharmaceutical company has delivered samples of a potential vaccine for the coronavirus to laboratories in the U.S. for human testing, with a view towards having widespread distribution of the medicine by the end of the year, NPR News reports.
U.S. drug manufacturer Pfizer, and its German partner, BioNTech SE, announced this week that human trials of the vaccine it’s developing should be under way soon, and indeed, may have tens of millions of vials of the medicine ready for distribution by this winter.
Already, 360 human test subjects in the U.S. have received doses of one of several potential vaccines the company is working on, while another 200 have received it in Germany.
0 comments :
Post a Comment